Trial reportJournal of vascular surgery2012
Optimal exercise program length for patients with claudication.
Trial report in Journal of vascular surgery, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 7 syntheses or guidelines pooled it.
- A systematic review of exercise intervention reporting quality and dose in studies of intermittent claudication.Vascular · 2023Pooled it
- Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: A systematic review and meta-analysis.Vascular medicine (London, England) · 2022Pooled it
- Network Meta-Analysis Comparing the Outcomes of Treatments for Intermittent Claudication Tested in Randomized Controlled Trials.Journal of the American Heart Association · 2021Pooled it
- Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.The Cochrane database of systematic reviews · 2018Pooled it
- Exercise for intermittent claudication.The Cochrane database of systematic reviews · 2017Pooled it
- Pooled it
- Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis.Sports medicine (Auckland, N.Z.) · 2015Pooled it
- Duration of Supervised Exercise Necessary for Meaningful Improvement in Peripheral Artery Disease.Journal of the American Heart Association · 2025Trial
- Trial
- Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study.Contemporary clinical trials · 2013Trial
- Enrollment of Historically Underrepresented Groups in Peripheral Arterial Disease Trials: A Systematic Review.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Review
- Article
- Supervised exercise training improves cardiorespiratory fitness and reduces perioperative risk in peripheral artery disease patients with intermittent claudication.Annals of the Royal College of Surgeons of England · 2024Article
- Exercise Therapy in the Management of Peripheral Arterial Disease.Mayo Clinic proceedings. Innovations, quality & outcomes · 2023Review
- Effects of aerobic and combined training on pain-free walking distance and health-related quality of life in patients with peripheral artery disease: a randomized clinical trial.Jornal vascular brasileiro · 2023Article
- Provision of exercise services in patients with peripheral artery disease in the United Kingdom.Vascular · 2022Article
- Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy.Journal of the American Heart Association · 2021Article
- Adherence and exercise mode in supervised exercise therapy for peripheral artery disease.Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing · 2020Article
- Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners.BMJ open sport & exercise medicine · 2020Review
- Peripheral arterial disease: Scoping review of patient-centred outcomes.International wound journal · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThis prospective, randomized controlled clinical trial determined whether an optimal exercise program length exists to efficaciously change claudication onset time (COT) and peak walking time (PWT) in patients with peripheral artery disease and claudication.
methodsThe study randomized 142 patients to supervised exercise (n = 106) or a usual care control group (n = 36), with 80 completing the exercise program and 27 completing the control intervention. The exercise program consisted of intermittent walking to nearly maximal claudication pain 3 days per week. COT and PWT were the primary outcomes obtained from a treadmill exercise test at baseline and bimonthly during the study.
resultsAfter exercise, changes in COT (P < .001) and PWT (P < .001) were consistently greater than changes after the control intervention. In the exercise program, COT and PWT increased from baseline to month 2 (P < .05) and from months 2 to 4 (P < .05) but did not significantly change from months 4 to 6 (P > .05). When changes were expressed per mile walked during the first 2 months, middle 2 months, and final 2 months of exercise, COT and PWT only increased during the first 2 months (P < .05).
conclusionsExercise-mediated gains in COT and PWT occur rapidly within the first 2 months of exercise rehabilitation and are maintained with further training. The clinical significance is that a relatively short 2-month exercise program may be preferred to a longer program to treat claudication because adherence is higher, costs associated with personnel and use of facilities are lower per patient, and more patients can be trained for a given amount of personnel time and resource utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.